Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Quality of Life (QOL) in Patients Registered With "Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer (JMTO LC00-03)"

NCT00242983 is registered in ClinicalTrials.gov with National Hospital Organization Kinki-chuo Chest Medical Center as lead sponsor.

NCT NCT00242983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Quality of Life (QOL) in Patients Registered With "Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer (JMTO LC00-03)"
Lead sponsor
National Hospital Organization Kinki-chuo Chest Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2004
Completion date
Not reported
Enrollment
Not reported
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer